Correction to: Full population results from the core phase of CompLEEment-1, a phase 3b study of ribociclib plus letrozole as first-line therapy for advanced breast cancer in an expanded population.
第一作者:
Michelino,De Laurentiis
第一单位:
Division of Breast Medical Oncology, Department of Breast and Thoracic Oncology Director, Istituto Nazionale Tumori IRCCS "Fondazione Pascale", Napoli, Italy. m.delaurentiis@istitutotumori.na.it.
作者:
DOI
10.1007/s10549-021-06374-6
PMID
34625861
发布时间
2022-01-27
- 浏览1
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



